Friday, May 9, 2025

Marc ZERBOLA CHALLANDE

224 POSTS
Marc has been involved in the Stock Market Media Industry for the last +5 years. After obtaining a college degree in engineering in France, he moved to Canada, where he created Money,eh?, a personal finance website.

Exclusive articles:

OS Therapies Pioneers Hope for Osteosarcoma Patients 

OS Therapies is advancing therapies focused on HER-2 positive osteosarcoma, addressing a critical unmet need. The company draws inspiration from "Osteo-Angels," individuals whose battles against...

LiveOne’s Path to Growth and Success

LiveOne reported a consolidated revenue of $33.1 million in Q1 of Fiscal Year 2025, continuing its upward momentum. Collaborations with companies like Tesla and TextNow...

Everything You Need to Know About the Stock Markets on 8/19

AMD announced a $4.9 billion acquisition of server builder ZT Systems to bolster its position in AI and high-performance computing, positively impacting its stock. Goldman...

Everything You Need to Know About the Stock Markets on 8/16

Asian markets surge as U.S. recession fears ease. Rivian halts production temporarily, impacting stock. Bayer shares soar following a legal victory in the U.S. Asian Markets Rally...

Investment Opportunities in a Shifting Market: Rate Cuts and One Stock Pick

A record 93% of asset managers expect short-term interest rates to decline within the next year, signaling potential growth in corporate profits and stock...

Breaking

Trump’s New Tariffs Send Shockwaves Across Key Sectors

President Donald Trump is making headlines again this week...

Buffett Passes the Torch: What’s Next for Berkshire?

Shares of Berkshire Hathaway (NYSE: BRK.A, BRK.B) took a...

NurExone Biologic (NRX): A Biotech Stock Turning Heads in 2025

NurExone Biologic Inc. (TSXV: NRX, OTCQB: NRXBF), an Israeli-based...

Mangoceuticals (NASDAQ: MGRX): A Small-Cap Contender with Major Upside in Men’s Health and Wellness

Summary Mangoceuticals, Inc. (NASDAQ: MGRX) is transforming from a niche...
spot_img